quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:03:38·2d
SECFiling
UnitedHealth Group Incorporated logo

SEC Form DEF 14A filed by UnitedHealth Group Incorporated

UNH· UnitedHealth Group Incorporated
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • UNH
    UnitedHealth Group Incorporated
    Health Care

Recent analyst ratings

  • Apr 22UpdateArgus$400.00
  • Apr 7UpdateHSBC Securities$300.00
  • Apr 1UpdateRaymond James$330.00
  • Oct 29UpdateDeutsche Bank$333.00
  • Oct 14UpdateGoldman$406.00
  • Jul 31UpdateRobert W. Baird$198.00

Related

  • PR3h
    UnitedHealthcare Champions Industry Effort to Standardize Prior Authorization Requirements
  • ANALYST2d
    UnitedHealth upgraded by Argus with a new price target
  • SEC2d
    SEC Form DEFA14A filed by UnitedHealth Group Incorporated
  • SEC3d
    UnitedHealth Group Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR3d
    UnitedHealth Group Reports First Quarter 2026 Results
  • PR3d
    UnitedHealthcare Eliminates Most Medical Prior Authorizations, Accelerates Payments for Key Rural Care Hospitals and Providers Nationwide
  • PR8d
    Seabury Resources for Aging® Launches Groundbreaking Fund with Support from UnitedHealthcare to Keep Vulnerable Seniors Housed as Demand for Aging-in-Place Aid Surges
  • PR10d
    UnitedHealthcare and Missouri Bootheel Regional Consortium Announce Collaboration to Strengthen Maternal Health and Patient-Provider Relationships
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022